<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02523196</url>
  </required_header>
  <id_info>
    <org_study_id>15-0520</org_study_id>
    <secondary_id>UL1TR001082</secondary_id>
    <nct_id>NCT02523196</nct_id>
  </id_info>
  <brief_title>Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)</brief_title>
  <official_title>Correlation and Comparison of the HepQuant® Disease Severity Index (DSI) With Hepatic Venous Pressure Gradient (HVPG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study plans to learn more about a new test to look at liver function, the HepQuant-Shunt&#xD;
      (HQ-Shunt). The HQ-Shunt is being evaluated for safety and effectiveness as an alternative to&#xD;
      Hepatic Venous Pressure Gradient testing in patients with liver disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of this study is to demonstrate the HQ-SHUNT is safe, simple to administer,&#xD;
      noninvasive, cost-effective, and well tolerated by patients. This study will compare the&#xD;
      HQ-SHUNT to Hepatic Venous Pressure Gradient (HVPG) testing. In this study, 100 consecutive&#xD;
      patients with various etiologies of liver disease who have undergone technically successful&#xD;
      HVPG testing as standard of care will also undergo HQ-SHUNT testing.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">February 23, 2017</completion_date>
  <primary_completion_date type="Actual">February 23, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Results of HepQuant SHUNT Test: Elimination Rate (IV Phase 1 Only; Min-1)</measure>
    <time_frame>Up to 90 minutes</time_frame>
    <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Results of HepQuant SHUNT Test: Systemic Clearance</measure>
    <time_frame>Up to 90 minutes</time_frame>
    <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension. Systemic Clearance (13C-CA; ml min-1)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Results of HepQuant SHUNT Test: Apparent Portal Clearance</measure>
    <time_frame>Up to 90 minutes</time_frame>
    <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Results of HepQuant SHUNT Test: Systemic Hepatic Filtration Rate</measure>
    <time_frame>Up to 90 minutes</time_frame>
    <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Results of HepQuant SHUNT Test: Portal Hepatic Filtration Rate</measure>
    <time_frame>Up to 90 minutes</time_frame>
    <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Results of HepQuant SHUNT Test: SHUNT</measure>
    <time_frame>Up to 90 minutes</time_frame>
    <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.&#xD;
SHUNT% is The percent of the oral dose of cholate that escapes hepatic extraction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Results of HepQuant SHUNT Test: DSI Score</measure>
    <time_frame>Up to 90 minutes</time_frame>
    <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.&#xD;
DSI range is from 0 to 50. 0 implies no disease; 50 implies severe end-stage disease.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Results of HepQuant SHUNT Test: STAT</measure>
    <time_frame>60 minutes</time_frame>
    <description>Compare HepQuant STAT test from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension. HepQuant STAT is a simple &quot;drink and draw&quot; blood-based clearance test that quantifies hepatic impairment from early through late stages of disease.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survey Patients on Their Experience of Having Both HQ-SHUNT and HVPG Procedures.</measure>
    <time_frame>Immediately post HepQuant SHUNT test (Baseline up to Day 60)</time_frame>
    <description>Overall experience and willingness to repeat 0-10 Scale 0 being no pain, 10 being severe pain 0 being no discomfort, 10 being severe discomfort 0 being no interference with daily life, 10 being unable to carry on activities 0 being very negative experience, 10 being very positive experience 0 being definitely not wanting to have the test again, 10 being very willing to have the test again</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hours for Test</measure>
    <time_frame>Baseline, up to Day 60</time_frame>
    <description>Number of hours it took for subjects to complete each test</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Liver Disease</condition>
  <arm_group>
    <arm_group_label>(HVPG) and HepQuant-SHUNT (HQ-Shunt)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Successful Hepatic Venous Pressure Gradiant (HVPG) testing is required prior to administration of the HepQuant-SHUNT test.&#xD;
Comparison of Disease Severity Index (DSI) from HQ-SHUNT with HVPG in identifying patients with cirrhosis and patients with varices.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HepQuant-SHUNT (Drug and Device) #65,123 (4D-cholate) and IND #65,121 (13C-cholate)</intervention_name>
    <description>The HQ-SHUNT test is being evaluated for safety and effectiveness as an alternative to Hepatic Venous Pressure Gradient (HVPG) testing in patients with liver disease</description>
    <arm_group_label>(HVPG) and HepQuant-SHUNT (HQ-Shunt)</arm_group_label>
    <other_name>HQ-SHUNT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hepatic Venous Pressure Gradient (HVPG)</intervention_name>
    <description>Hepatic Venous Pressure Gradient (HVPG) is a test for patients with liver disease</description>
    <arm_group_label>(HVPG) and HepQuant-SHUNT (HQ-Shunt)</arm_group_label>
    <other_name>(HVPG)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Liver disease patient scheduled to have an Hepatic Venous Pressure Gradient (HVPG)&#xD;
             procedure&#xD;
&#xD;
          -  At time of enrollment, being between the ages of 18 and 75&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Concomitant treatment with both a beta blocker and an ACE inhibitor&#xD;
&#xD;
          -  Concurrent hepatic malignancy. Patients with a history of treated HCC can be included&#xD;
             if there is no evidence of recurrent disease at the time of this study.&#xD;
&#xD;
          -  Unstable angina or history of myocardial infarction or congestive heart failure within&#xD;
             6 months prior to enrollment into this study&#xD;
&#xD;
          -  Renal insufficiency with chronic kidney disease stage 4 or 5 (GFR &lt; 30 mL/min/1.73m2)&#xD;
&#xD;
          -  Crohn's disease or any active intestinal inflammatory condition&#xD;
&#xD;
          -  Having had an ileal resection&#xD;
&#xD;
          -  Diabetic Gastroparesis&#xD;
&#xD;
          -  Pregnancy or intent to become pregnant. Urine pregnancy tests will be performed prior&#xD;
             to HQ SHUNT testing.&#xD;
&#xD;
          -  Inability to consent for one's self&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amanda Wieland, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado Denver (Leprino Building)</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Everson GT, Shiffman ML, Hoefs JC, Morgan TR, Sterling RK, Wagner DA, Lauriski S, Curto TM, Stoddard A, Wright EC; HALT-C Trial Group. Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial. Hepatology. 2012 Apr;55(4):1019-29. doi: 10.1002/hep.24752. Epub 2012 Mar 1.</citation>
    <PMID>22030902</PMID>
  </results_reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 3, 2015</study_first_submitted>
  <study_first_submitted_qc>August 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2015</study_first_posted>
  <results_first_submitted>February 3, 2020</results_first_submitted>
  <results_first_submitted_qc>January 15, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 5, 2021</results_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hepatic Venous Pressure Gradient (HVPG) testing</keyword>
  <keyword>HepQuant-SHUNT</keyword>
  <keyword>Liver Function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 17, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/96/NCT02523196/Prot_SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 30, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/96/NCT02523196/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Subjects can be excluded if they do not complete the study visit within 60 days of the HVPG testing or if they test positive in a urine pregnancy test the day of the HQ-SHUNT test.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Hepatic Venous Pressure Gradient (HVPG) and HepQuant-SHUNT (HQ</title>
          <description>Comparison of Disease Severity Index (DSI) from HQ-SHUNT with HVPG in identifying patients with cirrhosis and patients with varices.&#xD;
Successful Hepatic Venous Pressure Gradiant (HVPG) testing is required prior to administration of the HepQuant-SHUNT test.&#xD;
Hepatic Venous Pressure Gradient (HVPG): Hepatic Venous Pressure Gradient (HVPG) is a test for patients with liver disease&#xD;
HepQuant-SHUNT: The HQ-SHUNT test is being evaluated for safety and effectiveness as an alternative to Hepatic Venous Pressure Gradient (HVPG) testing in patients with liver disease</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Received HVPG</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Received HQ Shunt</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>HepQuant-SHUNT (HQ-Shunt)</title>
          <description>Comparison of Disease Severity Index (DSI) from HQ-SHUNT with HVPG in identifying patients with cirrhosis and patients with varices.&#xD;
HepQuant-SHUNT: The HQ-SHUNT test is being evaluated for safety and effectiveness as an alternative to Hepatic Venous Pressure Gradient (HVPG) testing in patients with liver disease</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.8" spread="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Wihite</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight</title>
          <units>Kg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87.1" spread="19.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Etiology of Liver Disease</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>NASH</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>HCV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Autoimmune Hepatitis</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Wilsons Disease</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Budd-Chiari Syndrome</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Cryptogenic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fibrosis Stage</title>
          <description>Fibrosis stage indicates the severity of scarring of the liver. Possible grades range from F0 to F4, with F0 indicating no scarring and F4 indicating the most severe scarring.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>F0</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>F1</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>F2-F3 (F2.5)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>F3</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>F4</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>NA</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Steatosis Grade</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Mild, &lt;5%</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mild, 5 to 33%</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderate, 33 to 66%</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severe, &gt;66%</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>NA</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Co-Morbid Conditions</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Obesity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diabetes Mellitus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypertension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dyslipidemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gout</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Extrahepatic autoimmune disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pulmonary hypertension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Malignancy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Standard Laboratory Tests: Serum Sodium</title>
          <units>mEq/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="136" spread="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Standard Laboratory Tests: Creatine, Glucose and Bilirubin</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Creatine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.71" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Glucose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="149" spread="140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bilirubin</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.75" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Standard Laboratory Tests: AST, Alkaline Phosphatase, ALT</title>
          <units>IU/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>AST</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46" spread="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Alkaline Phosphatase</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="108" spread="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ALT</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53" spread="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Standard Laboratory Tests: Albumin</title>
          <units>g/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.79" spread=".49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Standard Laboratory Tests: WBC, RBC and Platelets</title>
          <units>count/nL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>WBC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.22" spread="3.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>RBC</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.44" spread="0.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Platelets</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="218.45" spread="102.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Standard Laboratory Tests: Hemoglobin</title>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.38" spread="2.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Standard Laboratory Tests: Hematocrit</title>
          <units>%</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.60" spread="7.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Standard Laboratory Tests: INR</title>
          <units>No units (ratio)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.11" spread="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Standard Laboratory Tests: MELD Score</title>
          <description>Model For End-Stage Liver Disease (MELD) scores range from 6 to 40, and is a measure of how severe a patient's liver disease is. Higher scores represent more severe liver disease and a worse outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.35" spread="1.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Standard Laboratory Tests: Child-Turcotte-Pugh (CTP) Score</title>
          <description>The Child-Turcotte-Pugh (CTP) score measures cirrhosis severity. Scores range from 5-15, with higher scores indicating more severe cirrhosis and a worse outcome.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.35" spread="0.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Results of HepQuant SHUNT Test: Elimination Rate (IV Phase 1 Only; Min-1)</title>
        <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.</description>
        <time_frame>Up to 90 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HVPG &lt;6 mmHg</title>
            <description>Patients without portal hypertension</description>
          </group>
          <group group_id="O2">
            <title>HVPG ≥6 mmHg</title>
            <description>Patients with portal hypertension</description>
          </group>
          <group group_id="O3">
            <title>All Patients</title>
            <description>patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Results of HepQuant SHUNT Test: Elimination Rate (IV Phase 1 Only; Min-1)</title>
          <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.</description>
          <units>min-1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.104" spread="0.017"/>
                    <measurement group_id="O2" value="0.092" spread="0.023"/>
                    <measurement group_id="O3" value="0.099" spread="0.020"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Results of HepQuant SHUNT Test: Systemic Clearance</title>
        <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension. Systemic Clearance (13C-CA; ml min-1)</description>
        <time_frame>Up to 90 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HVPG &lt;6 mmHg</title>
            <description>Patients without portal hypertension</description>
          </group>
          <group group_id="O2">
            <title>HVPG ≥6 mmHg</title>
            <description>Patients with portal hypertension</description>
          </group>
          <group group_id="O3">
            <title>All Patients</title>
            <description>patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Results of HepQuant SHUNT Test: Systemic Clearance</title>
          <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension. Systemic Clearance (13C-CA; ml min-1)</description>
          <units>(13C-CA; ml min-1)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="463" spread="161"/>
                    <measurement group_id="O2" value="384" spread="137"/>
                    <measurement group_id="O3" value="427" spread="152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Results of HepQuant SHUNT Test: Apparent Portal Clearance</title>
        <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.</description>
        <time_frame>Up to 90 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HVPG &lt;6 mmHg</title>
            <description>Patients without portal hypertension</description>
          </group>
          <group group_id="O2">
            <title>HVPG ≥6 mmHg</title>
            <description>Patients with portal hypertension</description>
          </group>
          <group group_id="O3">
            <title>All Patients</title>
            <description>patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Results of HepQuant SHUNT Test: Apparent Portal Clearance</title>
          <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.</description>
          <units>d4-CA; ml min-1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1538" spread="525"/>
                    <measurement group_id="O2" value="975" spread="464"/>
                    <measurement group_id="O3" value="1285" spread="564"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Results of HepQuant SHUNT Test: Systemic Hepatic Filtration Rate</title>
        <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.</description>
        <time_frame>Up to 90 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HVPG &lt;6 mmHg</title>
            <description>Patients without portal hypertension</description>
          </group>
          <group group_id="O2">
            <title>HVPG ≥6 mmHg</title>
            <description>Patients with portal hypertension</description>
          </group>
          <group group_id="O3">
            <title>All Patients</title>
            <description>patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Results of HepQuant SHUNT Test: Systemic Hepatic Filtration Rate</title>
          <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.</description>
          <units>ml min-1 kg-1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.30" spread="1.09"/>
                    <measurement group_id="O2" value="4.47" spread="1.43"/>
                    <measurement group_id="O3" value="4.92" spread="1.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Results of HepQuant SHUNT Test: Portal Hepatic Filtration Rate</title>
        <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.</description>
        <time_frame>Up to 90 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HVPG &lt;6 mmHg</title>
            <description>Patients without portal hypertension</description>
          </group>
          <group group_id="O2">
            <title>HVPG ≥6 mmHg</title>
            <description>Patients with portal hypertension</description>
          </group>
          <group group_id="O3">
            <title>All Patients</title>
            <description>patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Results of HepQuant SHUNT Test: Portal Hepatic Filtration Rate</title>
          <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.</description>
          <units>ml min-1 kg-1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.83" spread="6.37"/>
                    <measurement group_id="O2" value="11.11" spread="5.24"/>
                    <measurement group_id="O3" value="14.81" spread="6.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Results of HepQuant SHUNT Test: SHUNT</title>
        <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.&#xD;
SHUNT% is The percent of the oral dose of cholate that escapes hepatic extraction</description>
        <time_frame>Up to 90 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HVPG &lt;6 mmHg</title>
            <description>Patients without portal hypertension</description>
          </group>
          <group group_id="O2">
            <title>HVPG ≥6 mmHg</title>
            <description>Patients with portal hypertension</description>
          </group>
          <group group_id="O3">
            <title>All Patients</title>
            <description>patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Results of HepQuant SHUNT Test: SHUNT</title>
          <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.&#xD;
SHUNT% is The percent of the oral dose of cholate that escapes hepatic extraction</description>
          <units>percentage</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.08" spread="9.89"/>
                    <measurement group_id="O2" value="47.50" spread="24.24"/>
                    <measurement group_id="O3" value="37.37" spread="19.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Results of HepQuant SHUNT Test: DSI Score</title>
        <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.&#xD;
DSI range is from 0 to 50. 0 implies no disease; 50 implies severe end-stage disease.</description>
        <time_frame>Up to 90 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HVPG &lt;6 mmHg</title>
            <description>Patients without portal hypertension</description>
          </group>
          <group group_id="O2">
            <title>HVPG ≥6 mmHg</title>
            <description>Patients with portal hypertension</description>
          </group>
          <group group_id="O3">
            <title>All Patients</title>
            <description>patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Results of HepQuant SHUNT Test: DSI Score</title>
          <description>Compare Disease Severity Index (DSI) from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension.&#xD;
DSI range is from 0 to 50. 0 implies no disease; 50 implies severe end-stage disease.</description>
          <units>score on a scale (DSI Score)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.64" spread="3.86"/>
                    <measurement group_id="O2" value="20.68" spread="6.30"/>
                    <measurement group_id="O3" value="17.36" spread="5.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Survey Patients on Their Experience of Having Both HQ-SHUNT and HVPG Procedures.</title>
        <description>Overall experience and willingness to repeat 0-10 Scale 0 being no pain, 10 being severe pain 0 being no discomfort, 10 being severe discomfort 0 being no interference with daily life, 10 being unable to carry on activities 0 being very negative experience, 10 being very positive experience 0 being definitely not wanting to have the test again, 10 being very willing to have the test again</description>
        <time_frame>Immediately post HepQuant SHUNT test (Baseline up to Day 60)</time_frame>
        <population>subjects that underwent HVPG and HQ-Shunt completed surveys</population>
        <group_list>
          <group group_id="O1">
            <title>Hepatic Venous Pressure Gradient (HVPG)</title>
            <description>Successful Hepatic Venous Pressure Gradiant (HVPG) testing is required prior to administration of the HepQuant-SHUNT test.&#xD;
Hepatic Venous Pressure Gradient (HVPG): Hepatic Venous Pressure Gradient (HVPG) is a test for patients with liver disease</description>
          </group>
          <group group_id="O2">
            <title>HepQuant-SHUNT (HQ-Shunt)</title>
            <description>Comparison of Disease Severity Index (DSI) from HQ-SHUNT with HVPG in identifying patients with cirrhosis and patients with varices.&#xD;
HepQuant-SHUNT: The HQ-SHUNT test is being evaluated for safety and effectiveness as an alternative to Hepatic Venous Pressure Gradient (HVPG) testing in patients with liver disease</description>
          </group>
        </group_list>
        <measure>
          <title>Survey Patients on Their Experience of Having Both HQ-SHUNT and HVPG Procedures.</title>
          <description>Overall experience and willingness to repeat 0-10 Scale 0 being no pain, 10 being severe pain 0 being no discomfort, 10 being severe discomfort 0 being no interference with daily life, 10 being unable to carry on activities 0 being very negative experience, 10 being very positive experience 0 being definitely not wanting to have the test again, 10 being very willing to have the test again</description>
          <population>subjects that underwent HVPG and HQ-Shunt completed surveys</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" spread="3.14"/>
                    <measurement group_id="O2" value=".35" spread=".59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Discomfort</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="2.89"/>
                    <measurement group_id="O2" value=".5" spread=".89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Interfere with Daily Life</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" spread="3.14"/>
                    <measurement group_id="O2" value="1.25" spread="1.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall Experience</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.2" spread="2.73"/>
                    <measurement group_id="O2" value="9.6" spread=".68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Willingness to Repeat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.65" spread="3.59"/>
                    <measurement group_id="O2" value="9.85" spread=".37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hours for Test</title>
        <description>Number of hours it took for subjects to complete each test</description>
        <time_frame>Baseline, up to Day 60</time_frame>
        <population>Number of hours</population>
        <group_list>
          <group group_id="O1">
            <title>Hepatic Venous Pressure Gradient (HVPG)</title>
            <description>Successful Hepatic Venous Pressure Gradiant (HVPG) testing is required prior to administration of the HepQuant-SHUNT test.&#xD;
Hepatic Venous Pressure Gradient (HVPG): Hepatic Venous Pressure Gradient (HVPG) is a test for patients with liver disease</description>
          </group>
          <group group_id="O2">
            <title>HepQuant-SHUNT (HQ-Shunt)</title>
            <description>Comparison of Disease Severity Index (DSI) from HQ-SHUNT with HVPG in identifying patients with cirrhosis and patients with varices.&#xD;
HepQuant-SHUNT: The HQ-SHUNT test is being evaluated for safety and effectiveness as an alternative to Hepatic Venous Pressure Gradient (HVPG) testing in patients with liver disease</description>
          </group>
        </group_list>
        <measure>
          <title>Hours for Test</title>
          <description>Number of hours it took for subjects to complete each test</description>
          <population>Number of hours</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0-3 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3-6 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-9 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>9-12 hours</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Results of HepQuant SHUNT Test: STAT</title>
        <description>Compare HepQuant STAT test from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension. HepQuant STAT is a simple &quot;drink and draw&quot; blood-based clearance test that quantifies hepatic impairment from early through late stages of disease.</description>
        <time_frame>60 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>HVPG &lt;6 mmHg</title>
            <description>Patients without portal hypertension</description>
          </group>
          <group group_id="O2">
            <title>HVPG ≥6 mmHg</title>
            <description>Patients with portal hypertension</description>
          </group>
          <group group_id="O3">
            <title>All Patients</title>
            <description>patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Results of HepQuant SHUNT Test: STAT</title>
          <description>Compare HepQuant STAT test from HQ-SHUNT for defining patients with (HVPG ≥6 mmHg) and without (HVPG &lt;6 mmHg) portal hypertension. HepQuant STAT is a simple &quot;drink and draw&quot; blood-based clearance test that quantifies hepatic impairment from early through late stages of disease.</description>
          <units>uM/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="11"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.61" spread="0.27"/>
                    <measurement group_id="O2" value="1.29" spread="0.73"/>
                    <measurement group_id="O3" value="0.92" spread="0.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 Weeks</time_frame>
      <desc>no adverse events</desc>
      <group_list>
        <group group_id="E1">
          <title>Hepatic Venous Pressure Gradient (HVPG)</title>
          <description>Successful Hepatic Venous Pressure Gradiant (HVPG) testing is required prior to administration of the HepQuant-SHUNT test.&#xD;
Hepatic Venous Pressure Gradient (HVPG): Hepatic Venous Pressure Gradient (HVPG) is a test for patients with liver disease</description>
        </group>
        <group group_id="E2">
          <title>HepQuant-SHUNT (HQ-Shunt)</title>
          <description>Comparison of Disease Severity Index (DSI) from HQ-SHUNT with HVPG in identifying patients with cirrhosis and patients with varices.&#xD;
HepQuant-SHUNT: The HQ-SHUNT test is being evaluated for safety and effectiveness as an alternative to Hepatic Venous Pressure Gradient (HVPG) testing in patients with liver disease</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Study did not reach enrollment goal of 110, therefore analysis was limited due to low power</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Amanda Wieland</name_or_title>
      <organization>University of Colorado Denver</organization>
      <phone>720-848-2291</phone>
      <email>amanda.wieland@cuanschutz.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

